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Staphylococcus aureus, a notorious human pathogen, is a major cause of the
community as well as healthcare associated infections. It can cause a diversity of
recalcitrant infections mainly due to the acquisition of resistance to multiple drugs, its
diverse range of virulence factors, and the ability to produce biofilm in indwelling medical
devices. Such biofilm associated chronic infections often lead to increase in morbidity
and mortality posing a high socio-economic burden, especially in developing countries.
Since biofilm formation and antibiotic resistance function dependent on each other,
detection of biofilm expression in clinical isolates would be advantageous in treatment
decision. In this premise, we attempt to investigate the biofilm formation and its
association with antibiotic resistance in clinical isolates from the patients visiting tertiary
health care hospitals in Nepal. Bacterial cells isolated from clinical samples identified
as S. aureus were examined for in-vitro biofilm production using both phenotypic and
genotypic assays. The S. aureus isolates were also examined for susceptibility patterns
of clinically relevant antibiotics as well as inducible clindamycin resistance using standard
microbiological techniques and D-test, respectively. Among 161 S. aureus isolates, 131
(81.4%) were methicillin resistant S. aureus (MRSA) and 30 (18.6%) were methicillin
sensitive S. aureus (MSSA) strains. Although a majority of MRSA strains (69.6%) showed
inducible clindamycin resistance, almost all isolates (97% and 94%) were sensitive
toward chloramphenicol and tetracycline, respectively. Detection of in vitro production of
biofilm revealed the association of biofilm with methicillin as well as inducible clindamycin
resistance among the clinical S. aureus isolates.
Keywords: biofilm, antibiotic resistance, inducible clindamycin resistance, ica genes, Staphylococcus aureus
INTRODUCTION
Staphylococcus aureus is a prominent cause of both community and healthcare associated
infections. It can cause minor skin infections to chronic systemic infections which often lead to
treatment failures (Lowy, 1998; Fitzpatrick et al., 2005; Dryden, 2009). The ability of S. aureus
to cause diverse recalcitrant infections is mainly due to the acquisition of resistance to multiple
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drugs, its diverse range of virulence factors, and its ability to
produce biofilm in indwelling medical devices (Lowy, 1998;
Chambers and Deleo, 2009; Archer et al., 2011; Figueiredo et al.,
2017). Such biofilm associated infections are often chronic and
persistent in nature and are the leading cause of morbidity
and mortality in healthcare settings (Moormeier et al., 2013).
Biofilms are essentially the extracellular polymeric substances
(EPS) that provide unique niches to bacterial cells. Low oxygen
availability and nutrient deficiency among others are features of
biofilm favoring the development of antibiotic tolerant persister
cells (Waters et al., 2016). In addition, biofilm also protect
the embedded bacterial cells from the host immune cells thus
facilitating the survival of pathogens for a prolonged period.
The ability of S. aureus to form biofilm on biotic and abiotic
surfaces is its major virulence property (Donlan and Costerton,
2002; McCann et al., 2008; Namvar et al., 2013). Biofilm’s EPS
is regulated by the expression of polysaccharide intercellular
adhesion (PIA) proteins. These proteins are encoded by the gene
locus icaADBC and mediate cell to cell adhesion, thus facilitating
biofilm formation. Indeed, ica adhesion genes are involved in the
pathogenesis progression facilitating the adhesion mechanisms
which explain the importance of these genes in S. aureus
virulence particularly associated with indwelling medical devices
(Otto, 2009; McCarthy et al., 2015). Among intercellular adhesion
(ica) genes, icaA and icaD have been reported to play a significant
role in biofilm formation (Mack et al., 1996; Cramton et al., 1999).
Hence, the detection of the ica locus along with the phenotypic
detection of biofilm is important in S. aureus and it would
improve the diagnostic decision for treatment of virulent clinical
specimens.
With the advancement in the medical field, use of indwelling
hospital devices has been prompted as part of treatment
for different diseases. However, this also increases the risk
of opportunistic bacterial infections such as staphylococcal
infections associated with implanted medical devices including
catheters, prosthetic devices, endotracheal tubes etc. (Fux et al.,
2005; von Eiff et al., 2005; Barrett and Atkins, 2014) Bacteria
within the biofilm are not only protected from the host immune
systems but also from the antimicrobial agents contributing
to treatment failures and recurrent infections (Kiedrowski and
Horswill, 2011; Waters et al., 2016). Although many studies
have demonstrated the involvement of S. aureus biofilm for
persistent infections (Fux et al., 2005; Archer et al., 2011;
Figueiredo et al., 2017), effective measures to eradicate biofilm
harboring bacterial cells in-vivo conditions are still poorly
identified. This highlights the importance of understanding
the mechanism of biofilm formation and its resistance to
antimicrobial substances for a successful treatment. In a resource-
limited country like Nepal, early detection of biofilm formation
in clinical isolates could be essentially an important practice in
prevention and management of nosocomial infections. Although
previous studies have demonstrated the prevalence of MRSA
cases (Mukhiya et al., 2012; Ansari et al., 2014; Bhatta et al.,
2016; Belbase et al., 2017), limited knowledge about prevalence
of biofilm associated MRSA is available in clinical samples,
especially in hospital device associated infections. In recent study,
we intended to evaluate the efficacy of both phenotypic and
genotypic methods to detect biofilm production (unpublished
data) in the clinical samples, which demonstrated TM among
all the phenotypic assays performed showed the best correlation
with the genotypic method in detecting biofilm formation. In this
study, we aim to examine and report the association of biofilm
formation with resistance to various clinically relevant drugs as
well as inducible clindamycin resistance (ICR) in the clinical
S. aureus isolates received in two tertiary care hospitals in Nepal.
MATERIALS AND METHODS
Collection and Identification of Isolates
Clinical isolates collected from tissues and medical devices
used in patients undergoing treatment in B & B Hospital
and Kathmandu Institute of Science and Technology (KIST)
Medical Hospital, Nepal were studied. As in the previous
study (unpublished data), the clinical samples received in the
laboratory including blood, pus, urine, CVC (central venous
catheter), tracheostomy tube, and tissues were examined. From
all clinical samples processed during study period, 161 isolates
were identified as S. aureus following standard microbiological
procedures (Cheesebrough, 2012). First, the isolates were
identified as staphylococcal strain on the basis of colony
morphology on Nutrient agar, Blood Agar and Mannitol Salt
Agar, Gram’s stain, and different biochemical tests (Bergey
and Holt, 1994). The yellow colored, moist, round, glistening
opaque colonies with β or weak hemolysis on blood agar
that were Gram positive cocci showing typical staphylococcal
bunch were subjected to a series of biochemical tests. The
isolates exhibiting positive test result to catalase, slide and
tube coagulase, methyl red, Voges Proskauer, nitrate reduction,
alkaline phosphatase, urease, gelatin hydrolyzing, fermentative,
DNase producer, lactose, mannitol, maltose, mannose, sucrose
and trehalose fermenting were confirmed as S.aureus (Collee,
1999).
Antimicrobial Susceptibility Test
The antimicrobial susceptibility test (AST) of all isolates was
performed by modified Kirby Bauer disk diffusion technique
following the guidelines of clinical and laboratory standards
institute (CLSI, 2015). We used different antibiotics based on
different mode of action and clinical relevance. The antibiotic
disks (HiMedia, India) used were penicillin-G (10 units),
cefoxitin (30 µg), ciprofloxacin (5 µg), clindamycin (2 µg),
chloramphenicol (30 µg), erythromycin (15 µg), gentamicin
(10 µg), tetracycline (30 µg) and cotrimoxazole (25 µg). Strains
showing resistance to three or more than three different classes
of antibiotics were considered multidrug resistant. Cefoxitin disk
was used to detect methicillin resistance. S. aureus ATCC 25923
was used as control strain in each AST assay along with the test
strains.
Screening of Inducible Clindamycin
Resistance
The double disk diffusion or D-zone test as outlined in CLSI
document M100-S24 (CLSI, 2015) was performed to examine
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FIGURE 1 | D-test showing inducible clindamycin resistance.
whether the erythromycin resistant isolates expressed inducible
clindamycin resistance. Briefly, the bacterial cells from the
S. aureus isolates were diluted to 0.5 McFarland standard and
spread over the Mueller Hinton agar (MHA) plate, on which
erythromycin (15 µg) disk and clindamycin (2 µg) disk were
placed 15–26 mm edge to edge apart. The plates were incubated
at 35◦C for 16–18 h in aerobic condition. Flattening of the zone of
inhibition of clindamycin adjacent to the erythromycin disk was
regarded as D-test positive (Figure 1).
Qualitative Assessment of Biofilm
Formation
The biofilm producing strains were screened by qualitative
methods such as Congo Red Agar (CRA) method and Tube
Method (TM). Strong slime producing reference strain ATCC
35984 (Micobiologics, United States) was used as positive strain
in each test performed. Qualitative detection of slime production
by CRA method was performed as described by Freeman et al.
(1989). Briefly, the Brain Heart Infusion (BHI) Broth (37g/l)
supplemented with sucrose (50 g/l), agar (10 g/l) and Congo red
dye (0.8 g/l) was used for CRA method. Congo red was prepared
as concentrated aqueous solution and autoclaved separately from
other constituents and was then added to the mixture when it was
cooled to 55◦C. The bacterial cells of isolates were streaked on
the agar media and incubated aerobically at 37◦C for 24 h. The
colonies that were black with dark consistency were considered
strong slime producers whereas pink colonies were slime non-
producers (Figure 2A).
Tube Method was performed as described (Christensen et al.,
1985). Briefly, trypticase soy broth (TSB) with 1% glucose were
inoculated with the loop-full of inoculum from overnight culture
plates and incubated for 24 h at 37◦C with shaking at 225 RPM.
The tubes were decanted slowly and washed with phosphate
buffer saline (PBS, pH 7.3) and air dried. Dried tubes were stained
with crystal violet (0.1%) and excess stain was removed and tubes
were washed with deionized water. Tubes were then dried in an
inverted position and observed for biofilm production. Assays
were performed in triplicates three different times. Biofilm was
considered positive when a visible film lined the wall and the
bottom of tube, and not the ring formation at liquid interface.
Based on the intensity of slime production, the result was
recorded as strong (+++), moderate (++), weak (+) and none
(−) (Figure 2B).
Quantitative Assessment of Biofilm
Formation
The quantitative assay for biofilm formation by TCP method
was carried out as described elsewhere (Christensen et al., 1985).
Shortly, bacterial cells from fresh culture were inoculated in TSB
with 1% glucose and incubated for 24 h at 37◦C in stationary
condition. After incubation, the culture was diluted (1:100)
with fresh TSB medium. From this diluted culture, 200 µl
was inoculated onto individual wells of sterile, polystyrene; flat-
bottom tissue culture plates (Tarson, India). TSB without cells
served as negative control to check sterility and non-specific
binding of media. The tissue culture plates were incubated for
24 h at 37◦C. After incubation, the content of each well was
gently removed by pipetting slowly and tapping the plates. The
wells were washed four times with PBS (pH 7.3) to remove free-
floating planktonic bacteria and air dried. The wells were then
fixed with 2% sodium acetate for 5 min and stained with 1%
of crystal violet for 15 min, rinsed thoroughly and repeatedly
with deionized water. Optical density (OD) of stained adherent
bacteria was determined with a micro ELISA auto reader by
taking the absorbance at 570 nm (Christensen et al., 1985).
Experiments for each strain were performed in triplicates and
repeated three times. Biofilm production was categorized as
negative, weak and high depending on the OD values of adherent
cells such as OD value < 0.120 as negative, those with OD > 0.120
and < 0.240 were regarded as weak biofilm-producers. An OD
value > 0.240 was indicative of high biofilm-producing bacterial
strains (Figure 2C).
Bacterial DNA Extraction and PCR
The genomic DNA from each S. aureus isolate was extracted
using the DNA extraction Kit (Thermo Fischer), following the
manufacturer’s instruction. The sequences of icaA and icaD
(accession number U43366) were taken from the GenBank
sequence of the National Center for Biotechnology Information
(NCBI) database. Primers specific for icaA and icaD were
designed by the Primer3 program and were purchased from
Solis Biodyne, (Denmark). The primer used for the detection
of icaA was forward 5′-TCTCTTGCAGGAGCAATCAA and
reverse 5′-TCAGGCACTAACATCCAGCA primer. The two
primers include a 188-bp region. For detection of icaD, 5′-
ATGGTCAAGCCCAGACAGAG was used as a forward primer
and 5′-CGTGTTTTCAACATTTAATGCAA was used as a
reverse primer with the product size of 198 bp (Supplementary
Figure S1).
Statistical Analysis
The statistical analysis was performed using SPSS 17.0 (SPSS Inc.,
Chicago, United States) software. Chi-square test was used to
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FIGURE 2 | (A) Biofilm producing isolates with black colonies on Congo Red Agar medium. (B) Biofilm production by tube method. Tube 1:+++, Tube 2:++, Tube
3:+, Tube 4: –, Tube 5: blank. (C) Biofilm production by Tissue Culture Plate method.
compare between groups of clinical isolates and P-values < 0.05
were considered statistically significant.
RESULTS
Majority of the Isolates Were MRSA
Which Also Showed Higher Rate of
Resistance to Other Drugs
Although initially the MRSA infections were confined to the
hospitals and patients frequenting to the health care facilities
(known as HA-MRSA), community associated MRSA (CA-
MRSA) have lately exploded posing economic burden to
developed countries (Archer et al., 2011). Given that the
prevalence of MRSA cases associated with hospital devices was
not reported in Nepal until date, we sought to examine the
MRSA strains among device associated staphylococcal isolates.
Among 161 S. aureus isolates, as indicated by cefoxitin disk
diffusion assay, 131 (81.4%) isolates were identified as MRSA
and the remaining 30 (18.6%) isolates as MSSA strains. The
MRSA isolates were significantly more resistant to majority
of the antibiotics than the MSSA strains. However, among all
antibiotics, chloramphenicol and tetracycline were found to be
the most effective against MRSA strains. AST result showed that
96.9 and 93.9% MRSA isolates were sensitive to chloramphenicol
and tetracycline, respectively (Table 1).
MRSA Isolates Showed Higher Rate of
Inducible Clindamycin Resistance
Clindamycin is frequently used as an alternative treatment to
MRSA patients as well as those showing allergies to penicillin.
However, S. aureus isolates showing in-vitro susceptibility to
clindamycin can frequently acquire the ICR in-vivo leading to
treatment failures (Levin et al., 2005). Hence, in this study, we
sought to examine the prevalence of ICR among MRSA isolates.
Among 161 S. aureus isolates, 127 (78.9%) were resistant to
erythromycin. When these isolates were subjected to D-test,
17 (10.5%) isolates showed resistant to both erythromycin and
clindamycin indicating constitutive MLSB phenotype. Out of
145 isolates that were sensitive to clindamycin, 56 (34.8%) also
showed positive D-test indicating inducible MLSB phenotype,
whereas 57 (35.5%) showed true sensitivity to clindamycin
as they were D-test negative indicating macrolide sensitive
(MS) phenotype. The susceptible phenotype (E-S, CD-S) was
exhibited by 32 (19.9%) of isolates (Table 2). Among MRSA, the
constitutive MLSB and inducible MLSB phenotype was 15 (9.3%)
and 42 (26.1%) respectively, while in MSSA, the constitutive
MLSB phenotype was 2(1.2%) and inducible MLSB phenotype
was 14 (8.7%). When the results were statistically compared, the
constitutive MLSB phenotype was determined to be 7.5 times
greater (P = 0.001, OR 9.9, 95% CI 2.5–39.2) and inducible
phenotype 3 times greater (P = 0.361, OR 2.4, 95% CI 0.367–15.7)
in MRSA than MSSA isolates. Taken together, these results
while demonstrating high prevalence of ICR in MRSA cases also
indicate the importance of implementation of D-test in regular
laboratory diagnostics to minimize the risk of treatment failures
due to this phenomenon.
Biofilm Production Was Stronger in
MRSA Strains
The structure of biofilm including the robustness and its
components show association with antibiotic resistance (Stewart
and Costerton, 2001; Ito et al., 2009). We therefore sought
to compare the thickness of biofilms formed between MRSA
and MSSA strains. Tube method (TM) was used to examine
the thickness of biofilm. The result demonstrated that biofilm
production was higher in MRSA strains as compared to the MSSA
strains not only quantitatively but also qualitatively. Strong
biofilm (referring to+++) indicated increased possibility of
antibiotic resistance or tolerance that is likely to lead to treatment
failures in MRSA infections (Table 3).
Biofilm Producing S. aureus Strains
Reveal Possession of icaA and icaD
Genes
Intercellular adhesion (ica) genes encode PIAs which in turn
regulate the biofilm formation (Arciola et al., 2015). Since icaA
and icaD genes are associated with biofilm formation, we sought
to examine the possession of these genes in all the isolates
studied. The amplification of these genes revealed 45 isolates;
29 MRSA and 16 MSSA strains harboring the icaA and icaD
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TABLE 1 | Antimicrobial Susceptibility Test (AST) results of MRSA and MSSA strains.
Antibiotics Potency (µg/disk) Resistant cases
MRSA (n = 131) MSSA (n = 30) Total (n = 161)
Cefoxitin 30 131(100%) 0 131(81.4%)
Penicillin 10 126(96.2%) 27(90%) 158(98.1%)
Tetracycline 30 8(6.1%) 1(3.3%) 9(5.5%)
Clindamycin 2 16(12.2%) 0 16(10%)
Chloramphenicol 30 4(3.1%) 0 4(2.4%)
Ciprofloxacin 5 102(77.9%) 17(56.7%) 119(73.9%)
Erythromycin 15 110(84%) 17(56.7%) 127(78.9%)
Cotrimoxazole 1.25/23.75 72(55%) 18(60%) 90(55.9%)
Gentamicin 10 58(44.3%) 9(30%) 67(41.6%)
AST of all isolates was performed by modified Kirby Bauer disk diffusion technique following the guidelines of clinical and laboratory standards institute (CLSI, 2015). The
number and percentage denotes the prevalence of resistance to the respective antibiotics by respective strains.
TABLE 2 | Prevalence of Inducible Clindamycin Resistance (ICR) in MRSA and
MSSA strains.
Phenotypes∗ MRSA MSSA Total
(n) % (n) % (n) %
E-S, CD-S 20 12.4 12 7.5 32 19.9
E-R, CD-R (constitutive
MLSB)
15 9.3 2 1.2 17 10.5
E-R, CD-S (inducible
MLSB, D-test positive)
42 26.1 14 8.7 56 34.8
E-R, CD-S (MS, D-test
negative)
54 33.6 3 1.9 57 35.5
Total 131 81.4 30 18.6 161 100
The double disk diffusion or D-zone test as outlined in CLSI document M100-S24
(CLSI, 2015) was performed to examine whether the erythromycin resistant isolates
expressed inducible clindamycin resistance. The flattening of zone of inhibition
around the clindamycin placed with erythromycin disk was reported as positive
for D-test. ∗E = Erythromycin, CD = Clindamycin, R = resistant, S = sensitive,
MLSB = Macrolides, Lincosamides and Streptogramin B.
TABLE 3 | Biofilm production among Staphylococcal isolates by Tube method
(TM).
Biofilm production MRSA MSSA Total P-value
Strong (+++) 18 (11.2%) 1 (0.6%) 19 (5.6%) 0.003
Moderate (++) 27 (16.8%) 15 (9.3%) 42 (26.1%)
Weak (+/−) 86 (53.4%) 14 (46.7%) 100 (62.1%)
The visible lining of the inner wall of the tube from overnight culture of the bacterial
cells after washing with PBS and stained with crystal violet. Based on the visual
intensity of the lining, the tubes were reported as strong, moderate and weak biofilm
producers.
genes. We observed no significant difference in-vitro biofilm
production between MRSA and MSSA strains in phenotypic
methods while genotypic assay demonstrated MSSA strains
possessing significantly higher number of ica genes as compared
to the MRSA strains (Table 4). This is likely because the MSSA
strains are dependent on icaADBC encoded PIA to regulate
the biofilm formation. On the other hand, MRSA strains more
commonly are dependent on extracellular DNA (eDNA), cell
surface proteins and major autolysin (McCarthy et al., 2015).
Biofilm Producing Strains That Harbor
icaAD Genes Were Resistant to More
Number of Antibiotics as Compared to
the Planktonic Counterparts
Biofilms associated infections are refractory to antibiotics leading
to treatment failures and recurrent infections. The embedded
bacterial cells are protected from the antibiotics as well as host
immune factors by the biofilm matrix facilitating the proliferation
of pathogens despite the external stresses (Waters et al., 2016).
More importantly, biofilm cells themselves are extremely tolerant
to antibiotics leading to recalcitrant and persistent infections
(Moormeier et al., 2013). Indeed, as this phenomenon persists, a
sub-population eventually develops into the antibiotic resistant
clones, causing treatment failures (Fitzpatrick et al., 2005).
Indeed, biofilm and antibiotic resistance in S. aureus are among
the most important virulence factors that function dependent
on each other (McCarthy et al., 2015). Hence, in this study,
we sought to examine the antibiotic resistance pattern among
biofilm forming strains against clinically relevant antibiotics. Our
results demonstrate that the rate of resistance to majority of the
drugs was higher in biofilm producing strains especially that
harbor icaAD genes as compared to the icaAD negative strains
(Table 5).
DISCUSSION
Increasing cases of antibiotic resistance in staphylococcal
infections pose a serious threat to public health as well as
pronounced socio-economic burden across the world. S. aureus
is a major human pathogen that causes acute to chronic systemic
infections which are often refractory to antibiotics leading
to treatment failures. Such recalcitrant infections are mainly
associated with biofilms formed by S. aureus on indwelling
devices such as catheters, CVC, prostheses etc. (von Eiff et al.,
2005; Murugan et al., 2010; Prasad et al., 2012). Early detection
Frontiers in Microbiology | www.frontiersin.org 5 November 2018 | Volume 9 | Article 2749
fmicb-09-02749 November 24, 2018 Time: 16:19 # 6
Manandhar et al. Antibiotic Resistance Biofilm Producing Staphylococcus aureus
TABLE 4 | In-vitro detection of biofilm production by MRSA and MSSA strains by commonly used phenotypic assays (CRA, TM, and TCP), and genotypic assay
(detection of icaAD genes).
Method Biofilm MRSA MSSA Total P-value
CRA Positive 2(1.2%) 1(0.6%) 3(1.9%) 0.5092
Negative 129(80.1%) 29(18.0%) 158(98.1%)
TM Positive 45(28.0%) 16(9.9%) 61(37.9%) 0.0532
Negative 86(53.4%) 14(8.7%) 100(62.1%)
TCP Positive 70(43.5%) 14(8.7%) 84(52.2%) 0.5032
Negative 61(37.9%) 16(9.9%) 77(47.8%)
Detection of ica genes Positive 29(18.0%) 16(9.9%) 45(28%) 0.0006
Negative 102(63.4%) 14(8.7%) 116(72%)
TABLE 5 | Antimicrobial Resistance Pattern and Biofilm Formation in S. aureus
Isolates.
Antibiotics Biofilm detection methods
TM (n = 61) TCP (n = 84) icaAD genes (n = 45)
Penicillin 59 (96.7%) 77(91.7%) 43(95.6%)
Cefoxitin 45(73.8%) 46(54.8%) 29(64.4%)
Tetracycline 3(4.9%) 3(3.6%) 3(6.6%)
Clindamycin 2(3.3%) 6(7.1%) 3(6.6%)
Chloramphenicol 2(3.3%) 1(1.2%) 2(4.4%)
Ciprofloxacin 32(52.5%) 70(83.3%) 31(68.9%)
Erythromycin 29(47.5%) 36(42.9%) 28(62.2%)
Cotrimoxazole 20(32.8%) 24(28.6%) 26(57.8%)
Gentamicin 17(27.9%) 20(23.8%) 22(48.9%)
All the biofilm forming isolates detected by phenotypic and genotypic assays were
tested for the antibiotic resistant pattern as described above. The number and
percentage denotes the biofilm producing resistant strains against the respective
antibiotics.
of biofilm forming staphylococci therefore warrants one of the
most essential steps for prevention, management, and cure of
nosocomial infections. Although the prevalence of MRSA cases in
Nepal was previously reported (Mukhiya et al., 2012; Ansari et al.,
2014; Bhatta et al., 2016; Belbase et al., 2017), the use of genotypic
method to detect biofilm production in MRSA isolates was not
published. In this study, we aimed to identify the prevalence of
biofilm forming MRSA and MSSA in various clinical samples
via different phenotypic and genotypic methods and establish the
causal link of biofilm and resistance to multiple drugs in S. aureus
infections.
In this study, 161 isolates identified as S. aureus from
different clinical samples were tested for antibiotic susceptibility
pattern and in-vitro biofilm production by phenotypic and
genotypic methods. More than 80% S. aureus isolates were found
to be methicillin resistant. This result shows higher cases of
MRSA in comparison to the previous studies which reported
only 19–45.9% of MRSA cases in clinical samples (Mukhiya
et al., 2012; Ansari et al., 2014; Bazzoun et al., 2014; Bhatta
et al., 2016). In addition, resistance of S. aureus to multiple
antibiotics such as penicillin, cefoxitin, tetracycline, clindamycin
and chloramphenicol was also found to be high. In this study,
almost all isolates (98.1%) were resistant to penicillin which was
in accordance with previous observations by Ansari et al. (2014)
(94.7%) and Belbase et al. (2017) (97.4%). In addition, the rates
of resistance to ciprofloxacin (73.9%), erythromycin (78.9%)
and cotrimoxazole (55.9%) were also found to be in similar
rate to these studies. Ansari et al. (2014) in this study
highlighted the risk factors contributing to the increasing rate
of resistance in developing countries like Nepal. These factors
mainly include lack of regulation of antibiotics availability
even without prescription and prescription by unauthorized
personnel, self-medication, pharmacies promoting their products
through clinicians, and lack of laboratory facilities to detect
the antibiotic resistance among others (Ansari et al., 2014).
Fortunately, in this study, we observed that a majority of the
S. aureus including MRSA were susceptible to commonly used
antibiotics such as chloramphenicol and tetracycline. Being cheap
and easy to administer, these drugs could be established as an
ideal option for the preliminary treatment of staphylococcal
infections in Nepal.
We detected inducible clindamycin resistance in 80.7% of
isolates, which is significantly higher than previous studies that
reported only in 12.4 to 22.4% of cases in Nepal (Ansari et al.,
2014; Ghasemian et al., 2016; Belbase et al., 2017). In our study,
the MS phenotype and constitutive MLSB phenotype was higher
among MRSA (33.6 and 26.1%) when compared with MSSA (1.9
and 8.7%). In contrast, previous studies (Schreckenberger et al.,
2004; Levin et al., 2005; Sasirekha et al., 2014) showed higher
MLSB phenotypes in MSSA as compared to the MRSA strains.
The higher incidence of MLSB in our study is explained based
on difference in various influencing factors including population
studied, the geographical distribution, health care facilities and
prevalence of MRSA and MSSA in the particular epidemiological
area, (Schreckenberger et al., 2004; Sasirekha et al., 2014). These
findings, nonetheless, indicate the importance ofD-test in routine
laboratory diagnostics for preliminary identification of ICR
which would be implemented for effective clinical prescription
minimizing the treatment failures that are likely to occur due to
these phenomena.
Biofilm production was detected by both phenotypic
and genotypic assays. On evaluation of phenotypic assays
(unpublished data), modified TCP method showed the best
correlation with the presence of icaAD genes. All the phenotypic
methods revealed no significant difference in biofilm production
between MRSA and MSSA strains; consistent to the previous
study (Ghasemian et al., 2016). However, importantly, strong
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biofilm formation as measured qualitatively was significantly
higher in MRSA strains as compared to the MSSA strains.
Due to resource limitation, we could not identify the molecular
composition of the biofilms, but, all these results suggest the
association between biofilm and antibiotic resistance specially
methicillin, inducible clindamycin, ciprofloxacin, erythromycin
and cotrimoxazole in clinical isolates in Nepal.
In the previous study, we reported the molecular technique,
used for the first time in Nepal, to detect the biofilm
formation among S. aureus clinical isolates. Amplification of
these genes revealed 45 isolates possessing both icaA and
icaD genes including 70% of tube adherent S. aureus and all
the slime producing strains. We reasoned that the difference
in in-vivo and in-vitro conditions possibly contribute to the
physiological changes of the pathogen modulating biofilm
formation capabilities. For instance, ica genes are expressed in
the stressful environment such as high osmolarity, anaerobic
condition, high temperature, and sub-inhibitory presence of
some antibiotics (Dobinsky et al., 2003; Mirani et al., 2013;
Foulston et al., 2014; Moormeier et al., 2014; Arciola et al.,
2015). Studies have demonstrated biofilm formation via PIA-
independent mechanisms in S. aureus (Beenken et al., 2004;
Kogan et al., 2006; O’Neill et al., 2007; Rohde et al., 2007).
A number of transcriptional regulators have been reported in
ica-independent biofilm production. These include araC- type
transcriptional regulator or regulator of biofilm (rbf), which
controls the biofilm production by novel regulatory mechanism
(Lim et al., 2004). Likewise, biofilm-associated protein (Bap); the
first gene is known to form biofilm via icaADBC independent
in S. aureus from bovine mastitis isolates (Cucarella et al.,
2001). Although initially, it appeared to be absent in human
clinical S. aureus isolates, Bap protein has now emerged as
being associated with more than 100 surface proteins that
are involved in biofilm formation (Lasa and Penades, 2006).
In the clinical S. aureus isolates of UAMS-1 strain, mutation
of ica locus showed little effect on biofilm formation, thus,
suggesting the presence of additional loci relevant to biofilm
formation (Beenken et al., 2004). Also, studies suggest the
regulation of biofilm by global regulator SarA in ica-independent
mechanisms (O’Gara, 2007). However, given the undeniable
role of icaADBC in biofilm matrix formation and that PCR
enables rapid diagnosis of slime producing virulent strains assays;
implementation of genotypic measure is strongly suggested in
routine diagnostic laboratory. Furthermore, S. aureus isolates
possessing the icaAD genes that showed higher resistance rate
to number of antibiotics, indicates its importance in routine
diagnostics.
CONCLUSION
Our findings show that icaAD genes are associated with biofilm
formation, but absence of these genes may not necessarily
exclude this property. Taken together, this study demonstrates
the high prevalence of MRSA isolates producing biofilms in
clinical staphylococcal samples. Since staphylococcal infections
have a significant impact on morbidity and mortality, prevention
and management of these infections remain a priority. This
study, while bringing additional information about the status
of biofilm producing clinical strains and their association with
multiple antibiotic resistances, highlights the importance of early
detection strategies in routine diagnostics. Implementation of
those will help to identify biofilm producing S. aureus cases
to prevent occurrence of treatment failures of staphylococcal
infections in Nepal.
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